How do you build a business case for laboratory automation in 2026?

You can build a business case for laboratory automation in 2026 by combining a clear ROI calculation with a structured argument covering cost reduction, risk mitigation, regulatory compliance, and sustainability. The strongest cases present both financial and non-financial returns, because procurement committees and lab directors increasingly evaluate investments on multiple dimensions. The questions below walk through each component you need to make that case convincingly.

What costs does laboratory automation actually reduce?

Laboratory automation reduces costs across four main categories: labor, consumables, solvent disposal, and error-related rework. Each of these is measurable, which makes them the foundation of any credible business case for laboratory automation. The savings are not marginal; in high-throughput contaminant analysis, they can be substantial enough to justify investment within two to three years.

Labor and time costs

Manual sample preparation is one of the most time-intensive activities in an analytical laboratory. Trained analysts spend hours on repetitive steps that automated systems can execute overnight or unattended. Automation frees those analysts for higher-value tasks such as data interpretation, method development, and client communication. This is especially relevant in 2026, when qualified laboratory staff remain difficult to recruit and retain across Europe and North America.

Solvent and disposal costs

Organic solvent consumption is a significant ongoing expense in laboratories analyzing persistent organic pollutants. Modern automated sample preparation systems can reduce solvent use to less than 100 mL per sample, and many eliminate the need for dichloromethane entirely. This directly cuts purchasing costs and, critically, reduces hazardous waste disposal costs, which are subject to increasing regulatory fees and environmental levies across the EU.

How do you calculate ROI on an automated sample preparation system?

To calculate ROI on an automated sample preparation system, subtract the total annual cost of the system (amortized purchase price plus maintenance) from the total annual savings it generates, then divide by the total annual cost and express as a percentage. A realistic model should account for labor savings, solvent reduction, fewer reruns, and increased sample throughput capacity.

Start by establishing your current cost-per-sample baseline. Include analyst time, consumables, solvents, waste disposal, and a proportion of instrument time. Then model the same cost-per-sample with automation in place. The difference, multiplied by your annual sample volume, gives you gross annual savings. Subtract system amortization and maintenance, and you have net annual benefit.

Throughput capacity is often underweighted in these calculations. If automation allows your laboratory to process significantly more samples with the same headcount, the revenue potential from that additional capacity can exceed the direct cost savings. For contract and environmental testing laboratories competing on turnaround time, this is frequently the strongest argument in the entire business case for laboratory automation.

What non-financial benefits strengthen a lab automation business case?

Non-financial benefits that strengthen a lab automation business case include improved data reproducibility, elimination of cross-contamination risk, enhanced staff safety, and greater regulatory defensibility. These factors carry real weight with quality managers, accreditation bodies, and clients, even though they do not appear directly on a cost spreadsheet.

Reproducibility is particularly important for ISO 17025-accredited laboratories, where method consistency is a core requirement. Automated systems apply the same conditions to every sample, removing operator-to-operator variability that can affect results and require costly investigation. When an accreditation audit or client inquiry asks how your laboratory ensures consistency, a documented automated workflow is a far stronger answer than a reliance on individual technique.

Staff safety is another argument that resonates with health and safety officers and lab managers. Eliminating manual handling of hazardous solvents such as dichloromethane reduces occupational exposure risk. This has both ethical and liability dimensions that procurement committees, particularly in regulated industries, take seriously.

Sustainability credentials are increasingly valued by clients and required by procurement policies in the public and food industry sectors. A laboratory that can demonstrate reduced solvent consumption and lower chemical waste generation has a tangible differentiator when competing for contracts.

Who needs to approve a laboratory automation investment?

A laboratory automation investment typically requires approval from three groups: the laboratory manager or technical director who validates the operational case, the finance or procurement officer who evaluates the financial case, and senior management or a board-level decision-maker who authorizes capital expenditure above a threshold. In larger organizations, a quality or compliance officer may also need to sign off.

Building a business case means preparing arguments tailored to each audience. The laboratory manager needs to see that the system integrates with existing workflows, meets method requirements, and is supported by training and technical assistance. The finance officer needs a clear payback period and total cost of ownership. Senior management needs a strategic framing: how does this investment support the laboratory’s growth, compliance posture, or sustainability commitments?

Understanding the internal approval process before you begin building the case saves significant time. Identify who holds budget authority, what the capital expenditure threshold is, and whether a formal tender or vendor comparison is required. Aligning your documentation to those requirements from the start makes the approval process faster and more predictable.

What’s the difference between automated SPE and fully automated cleanup systems?

Automated SPE (Solid Phase Extraction) systems automate the extraction and concentration of target analytes from liquid or dissolved samples using cartridges or disks. Fully automated cleanup systems go further, automating the entire purification sequence after extraction, including lipid removal, fractionation, and preparation of the final extract for instrumental analysis. The two serve different stages of the sample preparation workflow and are often complementary rather than interchangeable.

Automated SPE is well suited to high-throughput applications involving water, dissolved samples, or matrices where extraction is the primary challenge. Systems designed for PFAS, pesticides, hormones, and other emerging contaminants in large-volume water samples, for example, benefit from automated SPE that can process multiple channels in parallel.

Fully automated cleanup systems are essential when the analytical target requires extensive purification before measurement, as is the case with dioxins, PCBs, PBDEs, and PCNs in complex matrices such as food, feed, soil, and sludge. These matrices contain co-extracted lipids and other interferents that must be systematically removed before the sample reaches the instrument. A fully automated cleanup platform manages this entire sequence without analyst intervention, ensuring consistent purification quality across every sample in a batch.

For laboratories analyzing a broad range of contaminants, the most capable setups combine both technologies: automated SPE systems for extraction and a dedicated cleanup platform for purification, connected into an integrated workflow.

When is the right time to invest in lab automation?

The right time to invest in laboratory automation is when manual workflows are creating a measurable bottleneck, whether through capacity constraints, reproducibility problems, high staff turnover in technical roles, or growing pressure to reduce solvent use and chemical waste. Waiting for a crisis to force the decision typically means absorbing avoidable costs for longer than necessary.

Several conditions signal that the timing is right:

Sample volumes are growing faster than analyst capacity can scale
Turnaround time is becoming a competitive disadvantage
Regulatory requirements are tightening around contaminant thresholds or reporting standards
A laboratory is preparing for ISO 17025 accreditation or renewal and needs to demonstrate method consistency
Solvent costs and disposal fees are rising materially year over year
Staff are spending significant time on repetitive preparation steps that could be automated

In 2026, the external environment adds further urgency. EU regulations on persistent organic pollutants, PFAS, and food safety contaminants continue to evolve, and laboratories that automate now are better positioned to adapt quickly to new method requirements. Automated cleanup platforms can often be reconfigured for new analytes without replacing the core system, which protects the investment against future regulatory change.

Budget cycles also matter. If capital expenditure decisions are made annually, building the business case three to four months before the budget window opens gives stakeholders time to evaluate the proposal properly rather than deferring it to the following cycle.

How DSP-Systems supports your lab automation investment decision

DSP-Systems works with laboratories across Europe and North America to identify the right automated sample preparation solution for their specific analytical needs and workflow. Whether you are evaluating your first automated system or expanding an existing setup, DSP-Systems offers:

Expert guidance on system selection for dioxins, PCBs, PFAS, pesticides, and other contaminants across complex matrices
Pre-installation programming and application testing aligned with EPA and CEN standards
Turnkey laboratory setups and method development support
Training courses and ongoing technical support to maximize system performance
Access to the GO-EHT fully automated cleanup platform, the SPE2000, the AutoEmpore, and the SER-158 solvent extractor
Outsourced analytical services for laboratories that need capacity before their own system is in place

If you are building a business case for laboratory automation and want to discuss the technical and commercial details, contact DSP-Systems to speak with a specialist who can provide system-specific data to support your internal approval process.

Veelgestelde vragen

How long does it typically take to implement a laboratory automation system from purchase to full operation?

Implementation timelines vary depending on system complexity and laboratory readiness, but most automated sample preparation systems can be operational within four to twelve weeks of delivery. This includes installation, pre-installation programming, method validation, and analyst training. Working with a vendor who provides turnkey setup and pre-configured application methods — aligned with EPA or CEN standards — significantly compresses this timeline and reduces the risk of delays during commissioning.

What if our sample volume is too low to justify a full automation investment right now?

Lower current sample volumes do not necessarily disqualify a lab from making a strong business case — especially if volume growth is projected or if reproducibility, safety, and compliance benefits carry significant weight in your organization. In cases where capital investment is difficult to justify immediately, some vendors offer outsourced analytical services as a bridge solution, allowing your laboratory to access automated workflows while building the internal case for your own system. It is also worth modeling the revenue potential of increased throughput capacity, which often shifts the ROI calculation even at moderate current volumes.

How do we handle method validation after switching from manual to automated sample preparation?

Switching to automation requires a formal method validation or verification exercise to demonstrate that the automated workflow produces results equivalent to — or better than — the manual method, particularly for ISO 17025-accredited laboratories. This typically involves running parallel analyses on reference materials and real samples, documenting precision, recovery, and reproducibility data. Many vendors provide application-specific validation data and method development support to accelerate this process, which should be factored into both the implementation timeline and the business case.

What are the most common mistakes laboratories make when building an automation business case?

The most common mistake is building a case based solely on direct cost savings while underweighting throughput capacity gains, regulatory risk reduction, and non-financial benefits that matter to quality and compliance stakeholders. A second frequent error is failing to map the internal approval process early, which leads to proposals that answer the wrong questions for the wrong audience. Finally, laboratories often underestimate the cost of inaction — the ongoing losses from rework, staff time on repetitive tasks, and competitive disadvantage from slower turnaround times should be explicitly quantified in the business case.

Can automated cleanup systems handle multiple contaminant classes, or do we need separate systems for different analytes?

Modern fully automated cleanup platforms are designed to handle multiple contaminant classes through reconfigurable methods and interchangeable column sequences, meaning a single system can be programmed for dioxins and PCBs, PBDEs, PCNs, and other persistent organic pollutants without replacing hardware. This flexibility is a key factor in protecting your investment against future regulatory changes that introduce new target analytes or revised method requirements. When evaluating systems, it is worth asking vendors specifically which analyte classes are supported and how method changeovers are managed in practice.

How should we compare vendors when evaluating automated sample preparation systems?

Beyond purchase price, vendor comparison should assess total cost of ownership — including maintenance contracts, consumables, and software updates — as well as the quality and availability of application support, training, and technical service in your region. Ask each vendor for system-specific performance data on the matrices and contaminants you analyze, and request references from laboratories running comparable workflows. A vendor who can provide pre-installation programming, method validation support, and ongoing technical assistance adds measurable value that should be weighed alongside the hardware specifications.

Is laboratory automation compatible with existing LIMS and data management systems?

Most modern automated sample preparation systems can export data in standard formats that integrate with Laboratory Information Management Systems (LIMS), though the depth of integration varies by platform and vendor. Before purchase, confirm that the system’s software outputs are compatible with your LIMS and that audit trail and traceability requirements — particularly relevant for ISO 17025 and regulated industry clients — are fully supported. Raising data integration requirements early in the vendor conversation avoids costly surprises during implementation and ensures the automated workflow strengthens, rather than complicates, your data governance processes.

Gerelateerde artikelen

Deze inhoud is gegenereerd met behulp van AI en kan fouten bevatten.